Register Here

Topic:

Ring Therapeutics’ new modalities platform and focus on the upstream process

Speaker:

Alessandra Mancini, PhD, Senior Scientist in Upstream Process Development at Ring Therapeutics

Biography:

Alessandra Mancini, PhD is a Senior Scientist in Upstream Process Development at Ring Therapeutics, a pre-clinical Flagship Pioneering funded company. In her role, she develops upstream manufacturing strategies for a new class of targeted medicines – Ring Therapeutics’ novel vector conjugates.

Previously she worked in the Viral Vector Upstream Process Development team at 2seventy bio where she advanced gene and cell therapies from early to late-stage development.

Alessandra holds a MSc in Biomedical Science from University of Florence, Italy, a PhD in Endocrinology from Queen Mary University of London, UK and a Postdoctoral Fellowship in Neuroendocrinology from Brigham and Women’s Hospital and Harvard Medical School.